BioHistory Moment: Iditarod Trail used to transport diphtheria serum to Nome.

In 1925, a life-or-death race to save the children of Nome from a diphtheria epidemic made an international hero of one sled dog, and led to the creation of Alaska's Iditarod sled dog race. A diphtheria epidemic threatened remotely located Nome, and air transportation was unavailable to transport serum from Anchorage nearly a thousand miles away.

The solution: A relay of dog teams transported serum on the Iditarod Trail from Nenana to Nome, and every village enroute provided its best team and driver for the next leg continually moving the serum toward Nome. Gunnar Kaasen, a Norwegian musher, drove the final two legs into Nome behind his lead dog Balto through a blizzard with 80 mph winds to deliver 300,000 units of diphtheria antitoxin to Dr. Curtis Welch, the only doctor in Nome.

The serum arrived in time, prevented the epidemic and saved hundreds of lives. The 20 mushers had covered nearly 700 miles in slightly more than 127 hours in temperatures of minus40° Fahrenheit below zero and strong winds. The serum run received worldwide press coverage and the mushers received special gold medals and other recognition. In 1926, a statue of Balto, the heroic lead dog, was erected in New York's Central Park.

Learn about Seattle's Life Science Incubator Facility

Learn about this and other biotechnology, medical device and pharmaceutical facilities available for sale, lease or sublease in Rhode Island, regionally or nationwide.

Industry News...

Free News Release Posting & Archiving Service


• Bruker and Agilent announce agreement for Bruker to acquire certain Varian products  Bruker and Agilent Technologies announced that Bruker and Agilent have entered into a definitive asset purchase agreement. Bruker will acquire certain product lines of Varian, which Agilent has committed to divest.
  Bruker Corporation  March 09, 2010  
  
  
• Abbott enhances pharmaceutical pipeline with acquisition of Facet Biotech  Abbott and Facet Biotech announced a definitive agreement for Abbott to acquire Facet, enhancing Abbott's early- and mid-stage pharmaceutical pipeline.
  Abbott  March 09, 2010  
  
  
• Vaccinating children against flu helps protect wider community  Results of a clinical trial conducted in a largely self-contained religious community during the 2008-09 influenza season show that immunizing children against seasonal influenza can significantly protect unvaccinated community members against influenza as well.
  National Institutes of Health  March 09, 2010  
  
  
• Governor Rell unveils partnership to establish UConn Health Network  Governor M. Jodi Rell unveiled plans that would establish the UConn Health Network through a landmark partnership that will transform the delivery of healthcare in the state and lead to the creation of thousands of new jobs.
  Governor of Connecticut  March 09, 2010  
  
  
• Bristol-Myers Squibb and AstraZeneca announce the commencement of the SAVOR-TIMI 53  BMS and AstraZeneca announced the commencement of the "Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus" trial (SAVOR-TIMI 53), a multicenter, randomized, double-blind, placebo-controlled Phase 4 study, to evaluate treatment with ONGLYZA(TM)(saxagliptin).
  Bristol-Myers Squibb Company  March 09, 2010  
  
  

More... | Submit News Release | Advertising...

New Job Postings...

Free Job Posting Trial Offer

• CMC Associate Project Manager Seattle Genetics, Inc. (WA)
• Drug Safety Specialist Seattle Genetics, Inc. (WA)
• Clinical Research Nurse Supervisor Puget Sound Blood Center (WA)
• Senior Statistical Programmer Seattle Genetics, Inc. (WA)
• Director, Compliance Seattle Genetics, Inc. (WA)

More... | Job Advertising... | About Job Postings...

New Facilities Available...

ATC clean room constructors...validation guaranteed!

• 890 Embarcadero Road Property -- West Sacramento, CA
• CompleGen Lab/Office Space -- Seattle, WA
• Life Sciences Incubator -- Seattle, WA
• University of Iowa Oakdale Research Park Biotech Building -- Coralville, IA
• University of Iowa Oakdale Research Park BioVentures Center -- Coralville, IA

More... | Facility Advertising...

Upcoming Events...

• 03/09/2010: Differentiating Cell Types as a Precondition for Diagnosing and Treating Cancer
• 03/09/2010: 14th International Congress on Infectious Diseases
• 03/09/2010: Online Webinar: EDC and EHR in Clinical Trials
• 03/09/2010: 2010 Connecticut Science Fair
• 03/09/2010: Rutgers Mini-MBA: Business Essentials

More... | Submit Event | Event Advertising...